SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Insulet Corporation (PODD) trades at a trailing P/E of 57.2, forward P/E of 31.8. Trailing earnings yield is 1.75%, forward earnings yield 3.14%. PEG 0.39 (Peter Lynch undervalued ≤1.0). Graham Number is $41.25.
Criteria proven by this page:
- VALUE (42/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 31.8 (down from trailing 57.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.39 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.75% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.14% as earnings recover.
- Analyst consensus target $357.25 (+77.3% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
42/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PODD
Valuation Multiples
P/E (TTM)57.2
Forward P/E31.8
PEG Ratio0.39
Forward PEG0.39
P/B Ratio9.32
P/S Ratio5.22
EV/EBITDA29.7
Per Share Data
EPS (TTM)$3.51
Forward EPS (Est.)$6.33
Book Value / Share$21.53
Revenue / Share$38.49
FCF / Share$5.37
Yields & Fair Value
Earnings Yield1.75%
Forward Earnings Yield3.14%
Dividend Yield0.00%
Graham Number$41.25
SharesGrow IV$321.45 (+59.5%)
Analyst Target$357.25 (+77.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-74.0 |
1.22 |
33.82 |
5.82 |
- |
| 2017 |
-149.2 |
15.21 |
25.25 |
8.63 |
- |
| 2018 |
1,418.2 |
-12.65 |
22.01 |
8.28 |
- |
| 2019 |
894.3 |
3.73 |
136.68 |
14.05 |
- |
| 2020 |
2,433.6 |
-57.80 |
27.42 |
18.30 |
- |
| 2021 |
1,072.2 |
8.42 |
32.38 |
16.39 |
- |
| 2022 |
4,439.8 |
-60.42 |
42.87 |
15.65 |
- |
| 2023 |
73.4 |
0.02 |
20.66 |
8.92 |
- |
| 2024 |
43.7 |
0.43 |
15.10 |
8.83 |
- |
| 2025 |
80.9 |
-1.96 |
13.20 |
7.38 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.50 |
$366.99M |
$-28.88M |
-7.9% |
| 2017 |
$-0.46 |
$463.77M |
$-26.83M |
-5.8% |
| 2018 |
$0.05 |
$563.82M |
$3.29M |
0.6% |
| 2019 |
$0.19 |
$738.2M |
$11.6M |
1.6% |
| 2020 |
$0.10 |
$904.4M |
$6.8M |
0.8% |
| 2021 |
$0.25 |
$1.1B |
$16.8M |
1.5% |
| 2022 |
$0.07 |
$1.31B |
$4.6M |
0.4% |
| 2023 |
$2.80 |
$1.7B |
$206.3M |
12.2% |
| 2024 |
$5.66 |
$2.07B |
$418.3M |
20.2% |
| 2025 |
$3.48 |
$2.71B |
$247.1M |
9.1% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$6.34 |
$5.35 – $6.58 |
$3.31B |
$3.29B – $3.32B |
14 |
| 2027 |
$8.10 |
$5.98 – $8.75 |
$3.96B |
$3.67B – $4.03B |
14 |
| 2028 |
$10.24 |
$10.02 – $10.74 |
$4.7B |
$4.68B – $4.73B |
7 |
| 2029 |
$12.78 |
$12.09 – $13.09 |
$5.52B |
$5.29B – $5.62B |
2 |
| 2030 |
$14.53 |
$13.74 – $14.88 |
$6.14B |
$5.88B – $6.26B |
5 |
